|
|
|
42
|
25718
|
BETACORT 0.1% OINT (CAR) BETAMETHASONE
|
BETAMETHASONE
|
BETACORT
|
15G
|
A
|
4.62
|
4.62
|
TUBE
|
2
|
BOX
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
AVENTA BARBADOS
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
40
|
25737
|
BETACORT 0.1% CR (CAR/COL) BETAMETHASONE
|
BETAMETHASONE
|
BETACORT
|
15G
|
A
|
4.62
|
4.62
|
CREAM
|
2
|
TUBE
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
41
|
25737
|
BETACORT 0.1% CR (CAR) BETAMETHASONE (C)
|
BETAMETHASONE
|
BETACORT
|
15G
|
C
|
4.62
|
4.6212
|
TUBE
|
2
|
BOX
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
42
|
25737
|
BETACORT 0.1% CR (CAR) BETAMETHASONE
|
BETAMETHASONE
|
BETACORT
|
15G
|
A
|
4.62
|
4.62
|
TUBE
|
2
|
BOX
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
AVENTA BARBADOS
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
41
|
2573E
|
BETAMETHASONE 0.1% CR (GPC)
|
BETAMETHASONE
|
BETAMETHASONE
|
15G
|
A
|
2.34
|
2.3378
|
TUBE
|
2
|
BOX
|
GPC
|
NEW GUYANA PHARMACEUTICAL CORP. LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
40
|
2573V
|
BETNOVATE 0.1% CR (GSK/COL) BETAMETHASONE
|
BETAMETHASONE
|
BETNOVATE
|
30G
|
C
|
14.57
|
14.57
|
CREAM
|
0
|
TUBE
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
41
|
2573V
|
BETNOVATE 0.1% CR (GSK) BETAMETHASONE (C)
|
BETAMETHASONE
|
BETNOVATE
|
30G
|
C
|
15.68
|
15.6847
|
TUBE
|
2
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
42
|
2573V
|
BETNOVATE 0.1% CR (GSK) BETAMETHASONE
|
BETAMETHASONE
|
BETNOVATE
|
30G
|
C
|
16.47
|
16.47
|
TUBE
|
2
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
40
|
2592AD
|
FAMOTIDINE 10MG/ML INJ (DIL/AHI)
|
FAMOTIDINE
|
FAMOTIDINE
|
25X2ML
|
B
|
120.97
|
4.84
|
INJECTION
|
0
|
AMP
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
41
|
2592AJ
|
LADINE 10MG/ML INJ (LDP) FAMOTIDINE
|
FAMOTIDINE
|
LADINE
|
10X2ML
|
B
|
52.03
|
5.2029
|
AMP
|
0
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
HISTAMINE RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
2592AM
|
FAMOTIDINE 10MG/ML INJ (MAT)
|
FAMOTIDINE
|
FAMOTIDINE
|
25X2 ML
|
BQ
|
129.80
|
5.19
|
AMPG
|
0
|
AMP
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
HISTAMINE RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
2593AD
|
APO-SUCRALFATE 1G TAB (APO/COL)
|
SUCRALFATE
|
APO-SUCRALFATE
|
100'S
|
A
|
45.72
|
0.46
|
TABLET
|
120
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
562832
|
GI PROTECTANTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
40
|
2593DR
|
FAMOTIDINE 20MG TAB (APL/AHI)
|
FAMOTIDINE
|
FAMOTIDINE
|
100'S
|
C
|
24.85
|
0.25
|
TABLET
|
0
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
42
|
2593DU
|
SUCRALFATE 1G TAB (MAT)
|
SUCRALFATE
|
SUCRALFATE
|
100'S
|
A
|
83.81
|
0.84
|
TAB
|
120
|
BOTT
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
562832
|
GI PROTECTANTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
GI PROTECTANTS
|
|
|
|
|
40
|
2594AL
|
FAMOPSIN 40MG TAB (REM/SBI) FAMOTIDINE
|
FAMOTIDINE
|
FAMOPSIN
|
10X10
|
A
|
6.90
|
0.07
|
TABLET
|
30
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
41
|
2594AL
|
FAMOPSIN 40MG TAB (REM) FAMOTIDINE
|
FAMOTIDINE
|
FAMOPSIN
|
10X10
|
A
|
6.52
|
0.0652
|
TAB
|
30
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HISTAMINE RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
2594AL
|
FAMOPSIN 40MG TAB (REM) FAMOTIDINE
|
FAMOTIDINE
|
FAMOPSIN
|
10X10
|
B
|
12.80
|
0.13
|
TAB
|
30
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
HISTAMINE RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
2594C
|
FAMOTIDINE 40MG TAB (ZYP)
|
FAMOTIDINE
|
FAMOTIDINE
|
3X10
|
A
|
1.28
|
0.04
|
TAB
|
30
|
BLIS
|
ZYP
|
ZYPHAR'S PHARMACEUTICAL Pvt Ltd
|
RXP
|
RX PRO INC
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
HISTAMINE RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
2594EJ
|
FOMODIN 40MG TAB (ANC) FAMOTIDINE
|
FAMOTIDINE
|
FOMODIN
|
10X10
|
A
|
4.89
|
0.05
|
TAB
|
30
|
BLIS
|
ANC
|
AEONIM HEALTHCARE
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
HISTAMINE RECEPTOR ANTAGONIST
|
2026-02-11
|
|
|
|
40
|
26416
|
FLIXOTIDE 50MCG INHR (GSK/COL) FLUTICASONE
|
FLUTICASONE
|
FLIXOTIDE
|
120 DOSES
|
A
|
21.67
|
21.67
|
INHALER
|
1
|
INHR
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
481008
|
CORTICOSTEROIDS (RESPIRATORY)
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|